Your browser doesn't support javascript.
loading
A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors.
Moreno, Victor; Perets, Ruth; Peretz-Yablonski, Tamar; Fourneau, Nele; Girgis, Suzette; Guo, Yue; Hellemans, Peter; Verona, Raluca; Pendás, Natalia; Xia, Qi; Geva, Ravit; Calvo, Emiliano.
Afiliação
  • Moreno V; START Madrid-FJD. Hospital Fundación Jiménez Díaz, Madrid, Spain. victor.moreno@startmadrid.com.
  • Perets R; Rambam Health Care Campus, Technion - Israel Institute of Technology, Haifa, Israel.
  • Peretz-Yablonski T; The Sharett Oncology Institure, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
  • Fourneau N; Janssen Research & Development, Beerse, Belgium.
  • Girgis S; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Guo Y; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Hellemans P; Janssen Research & Development, Beerse, Belgium.
  • Verona R; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Pendás N; Janssen Research & Development, Madrid, Spain.
  • Xia Q; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Geva R; Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel.
  • Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
Invest New Drugs ; 41(1): 93-104, 2023 02.
Article em En | MEDLINE | ID: mdl-36538259
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Neoplasias Limite: Adult / Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Neoplasias Limite: Adult / Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha